Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Aubin

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Journal Des Maladies Vasculaires|July 25, 2015
[Prevention of venous thromboembolic events by fondaparinux 2.5 mg in general practice. ArchiMed Ville]I Mahé, J-P Daurès, D Pouchain, et al.
Journal Des Maladies Vasculaires|June 9, 2015
[Prevention of venous thromboembolic events by fondaparinux 2.5mg in patients hospitalized for an acute medical illness. ArchiMed Study]C Leroyer, I Mahé, J-P Daurès, et al.
Physical Review Letters|February 9, 2005
Semileptonic decays of d mesons in three-flavor lattice QCDC Aubin, C Bernard, C Detar, et al.
Physical Review Letters|October 4, 2005
Charmed-meson decay constants in three-flavor lattice QCDC Aubin, C Bernard, C Detar, et al.
Genes and Immunity|April 8, 2011
Interferon regulatory factor 5 gene variants and pharmacological and clinical outcome of Interferonβ therapy in multiple sclerosisS Vosslamber, L F van der Voort, I J van den Elskamp, et al.
Physical Review Letters|February 3, 2004
High-precision lattice QCD confronts experimentC T H Davies, E Follana, A Gray, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Journal Des Maladies Vasculaires|July 25, 2015
[Prevention of venous thromboembolic events by fondaparinux 2.5 mg in general practice. ArchiMed Ville]I Mahé, J-P Daurès, D Pouchain, et al.
Journal Des Maladies Vasculaires|June 9, 2015
[Prevention of venous thromboembolic events by fondaparinux 2.5mg in patients hospitalized for an acute medical illness. ArchiMed Study]C Leroyer, I Mahé, J-P Daurès, et al.
Physical Review Letters|February 9, 2005
Semileptonic decays of d mesons in three-flavor lattice QCDC Aubin, C Bernard, C Detar, et al.
Physical Review Letters|October 4, 2005
Charmed-meson decay constants in three-flavor lattice QCDC Aubin, C Bernard, C Detar, et al.
Genes and Immunity|April 8, 2011
Interferon regulatory factor 5 gene variants and pharmacological and clinical outcome of Interferonβ therapy in multiple sclerosisS Vosslamber, L F van der Voort, I J van den Elskamp, et al.
Physical Review Letters|February 3, 2004
High-precision lattice QCD confronts experimentC T H Davies, E Follana, A Gray, et al.
Pageof 1